Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telotristat ethyl for intraoperative carcinoid crisis in small bowel NET
NCT04672876Phase 2Withdrawn
- Sponsor
- University of Chicago
- Start
- Jan 2022
- Primary completion
- Oct 2022
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of telotristat ethyl in Carcinoid Crisis, sponsored by University of Chicago. Planned start Jan 2022; status: withdrawn.
02
Drugs
telotristat ethyl
03
Conditions
Carcinoid Crisis
Beyond the preview
Go deeper on NCT04672876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04672876.